| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4244645 | Médecine Nucléaire | 2008 | 10 Pages |
Abstract
This article seeks to describe the requirements, legal and technical, for the production, distribution and use of new radiopharmaceuticals PET (other than the 18FDG), describing the legislative framework in which we find ourselves, the characteristics of a production and types of synthesis and existing modules. A list of susceptible radiopharmaceuticals is presented that are being currently used in nuclear medicine by specifying the real possibilities of their production and use and which are the difficulties we face.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
R. Sánchez, J.I. Rayo, J. Serrano, J. Infante, Ma Luz DomÃnguez, L. GarcÃa, C. Durán,